Senti Biosciences, Inc.

Senti Biosciences, Inc.verified

SNTI

Price:

$4.15

Market Cap:

$19.04M

Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a mult...[Read more]

Industry

Biotechnology

IPO Date

2021-05-26

Stock Exchange

NASDAQ

Ticker

SNTI

The Enterprise Value as of December 2024 (TTM) for Senti Biosciences, Inc. (SNTI) is 43.27M

According to Senti Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.27M. This represents a change of 64.29% compared to the average of 26.34M of the last 4 quarters.

Senti Biosciences, Inc. (SNTI) Historical Enterprise Value (quarterly & annually)

How has SNTI Enterprise Value performed in the past?

The mean historical Enterprise Value of Senti Biosciences, Inc. over the last ten years is 442.87M. The current 43.27M Enterprise Value has changed 877.10% with respect to the historical average. Over the past ten years (40 quarters), SNTI's Enterprise Value was at its highest in in the September 2021 quarter at 4.34B. The Enterprise Value was at its lowest in in the December 2023 quarter at 1.74M.

Quarterly (TTM)
Annual

Average

442.87M

Median

397.16M

Minimum

16.29M

Maximum

1.35B

Senti Biosciences, Inc. (SNTI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Senti Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 90.50%

Maximum Annual Enterprise Value = 1.35B

Minimum Annual Increase = -95.90%

Minimum Annual Enterprise Value = 16.29M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202331.03M90.50%
202216.29M-95.90%
2021397.16M-5.26%
2020419.21M-68.96%

Senti Biosciences, Inc. (SNTI) Average Enterprise Value

How has SNTI Enterprise Value performed in the past?

The current Enterprise Value of Senti Biosciences, Inc. (SNTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

148.16M

5-year avg

442.87M

10-year avg

442.87M

Senti Biosciences, Inc. (SNTI) Enterprise Value vs. Peers

How is SNTI’s Enterprise Value compared to its peers?

Senti Biosciences, Inc.’s Enterprise Value is less than ZIVO Bioscience, Inc. (78.24M), greater than Cadrenal Therapeutics, Inc. Common Stock (19.09M), less than Foghorn Therapeutics Inc. (253.52M), greater than Quoin Pharmaceuticals, Ltd. (-607544.00), greater than SAB Biotherapeutics, Inc. (33.70M), greater than Cingulate Inc. (5.61M), greater than Bellicum Pharmaceuticals, Inc. (-5130674.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Lipella Pharmaceuticals Inc. (2.46M), less than Fennec Pharmaceuticals Inc. (160.46M), less than Monopar Therapeutics Inc. (122.81M), greater than Applied Molecular Transport Inc. (-5743713.00), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than SAB Biotherapeutics, Inc. (33.70M), greater than Connect Biopharma Holdings Limited (-53600395.00), less than Tyra Biosciences, Inc. (650.56M), greater than RAPT Therapeutics, Inc. (29.10M), greater than Xilio Therapeutics, Inc. (-973474.00), less than Mineralys Therapeutics, Inc. (527.82M),

Build a custom stock screener for Senti Biosciences, Inc. (SNTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senti Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Senti Biosciences, Inc. (SNTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Senti Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Senti Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Senti Biosciences, Inc. (SNTI)?

What is the 3-year average Enterprise Value for Senti Biosciences, Inc. (SNTI)?

What is the 5-year average Enterprise Value for Senti Biosciences, Inc. (SNTI)?

How does the current Enterprise Value for Senti Biosciences, Inc. (SNTI) compare to its historical average?